Pyr-T
Names
3-[2-(Pyrrolidin-1-yl)ethyl]-1H-indole
N,N-Tetramethylenetryptamine
Identifiers
3D model (JSmol)
YPubChem CID
CompTox Dashboard (EPA)
InChI=1S/C14H18N2/c1-2-6-14-13(5-1)12(11-15-14)7-10-16-8-3-4-9-16/h1-2,5-6,11,15H,3-4,7-10H2 Y
Key: CVTZCBLFHNGYDQ-UHFFFAOYSA-N Y
InChI=1/C14H18N2/c1-2-6-14-13(5-1)12(11-15-14)7-10-16-8-3-4-9-16/h1-2,5-6,11,15H,3-4,7-10H2
Key: CVTZCBLFHNGYDQ-UHFFFAOYAE
c2c(c1ccccc1[nH]2)CCN3CCCC3
Properties
C14H18N2
214.312 g·mol−1
193 to 194 °C (379 to 381 °F; 466 to 467 K) (HCl salt.)
170 to 180 °C (338 to 356 °F; 443 to 453 K) (Freebase at 0.05mm/Hg.)
2.74410
1.02x10−5mmHg
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
Pyr-T (N,N-tetramethylenetryptamine) is a lesser-known, possible psychedelic drug. Pyr-T was first characterized by S. Mitzal.[1] Toxicity testing was later performed by Hunt and Brimblecombe, and although a lethal dosage was found in rats, a value is not given.[2] In the book TiHKAL (Tryptamines I Have Known and Loved), neither the dosage nor the duration are reported.[3][4]
Pyr-T produces few to no effects in humans, but some behavioral changes were observed in animal tests.[2] Very little data exists about the pharmacological properties, metabolism, and toxicity of pyr-T.
